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Abstract Artiﬁcial oocyte activation using Ca2+ionophores or similar compounds is a widely applied technique in IVF laboratories.
This is all the more interesting as most of the agents aiming for intracellular Ca2+ increase do not result in physiological Ca2+ oscil-
lations but much rather cause a single Ca2+ transient. Two observations from mammals may explain why a rather non-physiological
single Ca2+ peak caused by ionophores is sufﬁcient to rescue cycles showing severe male factor infertility, deﬁcient oocyte matura-
tion, developmental problems in humans, or both. On the one hand, it has been shown that it is mainly the initial Ca2+ rise that drives
further downstream events, in particular calcium/calmodulin-dependent protein kinase II (CaMKII) action, and on the other, it is pos-
sible that this enzyme remains active even in the absence of Ca2+. It therefore seems that mammalian oocytes can respond to a wide
range of intracellular Ca2+ signals and have a surprisingly high degree of tolerance for changes in cytosolic Ca2+. As epigenetic con-
sequences or differences in gene expression have not been studied to date, artiﬁcial oocyte activation has to be considered as ex-
perimental and should only be applied with a proper indication.
© 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
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It has been known for decades that periodic changes in in-
ternal Ca2+ mediate a large range of cell functions involved
in oocyte activation and subsequent cell function. The ef-
fectiveness of these calcium oscillations depends on their
number, frequency, temporal modulation and amplitude.
On the other hand, cytosolic calcium deﬁciency, regard-
less of whether the problem is sperm- or oocyte-born, will
have a profound effect on cell physiology. Evidence shows that
in such cases, fertilization after intracytoplasmic sperm in-
jection (ICSI) (Ebner et al., 2012, 2015a; Montag et al., 2012)
and mitotic cleavage (Ebner et al., 2015b) may be severely
impaired. After all, it is generally acknowledged that intra-
cellular Ca2+ is limited and, once internal stores have been
depleted, the oocyte is reliant on inﬂux of extracellular Ca2+
to compensate for this loss (Berridge et al., 1998). The AOA
technique would facilitate such a mechanism.
As Vanden Meerschaut et al. (2014a) highlighted, AOA, in
particular using Ca2+ionophores such as A23187 or ionomycin,
is a widely applied technique in human IVF laboratories. The
problem with AOA, however, is that all application modes pub-
lished to date (Vanden Meerschaut et al., 2014a) are all but
standardized, which would be a prerequisite for the safe han-
dling of oocytes in clinical use, as well as preventing mean-
ingful comparison between different IVF studies. In general,
it is interesting that artiﬁcial activation is widely used, as most
of the compounds used for AOA do not result in physiologi-
cal Ca2+ oscillations but much rather cause a single Ca2+
transient.
Although it is evident that oscillatory Ca2+ signalling is the
normal stimulus during mammalian fertilization, Ducibella
et al. (2003) have highlighted whether periodical changes in
Ca2+ are indeed necessary for normal development.
http://dx.doi.org/10.1016/j.rbmo.2015.12.004
1472-6483/© 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Reproductive BioMedicine Online (2016) 32, 271–273
www.sciencedirect .com
www.rbmonl ine.com
In mammalian fertilization, the spatio–temporal informa-
tion about internal Ca2+ is transduced by downstream factors
that mediate oocyte activation and subsequent preimplan-
tation embryonic development. One such effector, CaMKII,
has been found to oscillate in temporal synchrony with re-
petitive Ca2+peaks (Markoulaki et al., 2003). This was dem-
onstrated not only after regular fertilization but also after
parthenogenetic activation (Winston and Maro, 1995) and mul-
tiple sequential ionophore pulses (Markoulaki et al., 2003).
It indicates that artiﬁcial Ca2+ recruitment results in a proper
biological downstream response. Even more interestingly,
CaMKII activity obviously rises and falls with the initial Ca2+
transient in a directly proportional manner (Markoulaki et al.,
2003), thus reﬂecting the situation commonly found in AOA
(presence of a single calcium rise). Although oscillatory Ca2+
signalling may be a mechanism to maintain the sensitivity of
CaMKII for the duration of Ca2+ signalling in regular fertiliza-
tion (Ducibella et al., 2003), autophosphorylation of CaMKII,
once activated, may keep the enzyme active even without
the presence of calcium (Johnson et al., 1998); a scenario that
would explain how a Ca2+ stimulus can be transmitted in the
absence of its physiological repetitive pattern.
Moreover, evidence shows that, in humans, any reduc-
tion in the frequency of Ca2+ peaks can be compensated by
both a higher amplitude and a longer total duration of the
same, thus increasing the total amount of calcium released
(Nikiforaki et al., 2014). This hypothesis is in agreement with
mammalian data showing that oocyte activation is tolerant
to perturbations in the calcium oscillation pattern as long as
the total amount of calcium release is uncompromised and
passes a critical threshold (Ozil et al., 2005; Toth et al., 2006).
For daily practice, this would mean that an increase in length
and number of exposures to ionophore could indeed show a
beneﬁt in selected cases (although this contradicts the need
for a standardized procedure).
Taken together, it seems that mammalian oocytes can
respond to a wide range of intracellular Ca2+ signalling pa-
rameters (Ducibella et al., 2003) and have a surprisingly high
degree of tolerance for prolonged changes in cytosolic Ca2+
(Ozil et al., 2005; Toth et al., 2006).
The simple fact, however, that AOA can rescue cycles
showing severe male factor infertility, deﬁcient oocyte
maturation (Kim et al., 2015), developmental problems, or
both, should not mask the non-physiological nature of iono-
phore treatment. Given the key role of Ca2+ oscillations in
regular ovum activation, it has been speculated that they
are linked to long-term development, possibly via chroma-
tin remodelling and reprogramming of gene expression
(Ducibella et al., 2003). The observed failure in the comple-
tion of oocyte activation (Vitullo and Ozil, 1992) as well as
the impairment in postimplantation viability of parthenoge-
netically activated mammalian oocytes (Ozil and Huneau,
2001) indicates that defective Ca2+ treatment could inter-
fere with epigenetic reprogramming of the genome which,
in turn, could result in an altered gene expression pattern
(Ozil and Huneau, 2001). This would affect protein synthe-
sis and degradation during the ﬁrst cell cycle (Kurokawa
and Fissore, 2003).
Recently, it became evident that the placenta of off-
spring born via assisted reproductive technologies has a
reduced methylation level at H19 (Nelissen et al., 2013), which
might explain the parallel ﬁnding that the epigenetic status
of children conceived after IVF or ICSI differs from that after
spontaneous conception (Whitelaw et al., 2014). The actual
extent to which AOA, as one of the upcoming laboratory tech-
nologies, might affect DNA methylation is unclear; however,
the absence of imprinting disorders in AOA live-births re-
ported so far (Deemeh et al., 2015; Vanden Meerschaut et al.,
2014b) suggests that theoretical changes in methylation might
not be correlated with the overall transcriptional levels of the
associated genes (Rancourt et al., 2012).
Considering the additional fact that most assisted repro-
duction techniques, such as ICSI, prolonged in-vitro culture
or cryopreservation are thought to be related to an altered
gene expression (Giritharan et al., 2010; Monzo et al., 2012),
it is a realistic scenario that AOA could affect gene expres-
sion. It seems, however, to be less than expected. Com-
pared with conventional IVF, the combination of ICSI with a
chemical activation step resulted in a gene expression pattern
that was found to be closer to IVF than to ICSI alone, sug-
gesting that AOA effectively mimics, at the genetic level, a
proportion of the events initiated by sperm entrance (Bridges
et al., 2011).
So it is reassuring that the continuous follow-up of chil-
dren born after AOA revealed that neonatal and
neurodevelopmental outcome of children aged between 3 and
10 years is within expected ranges (Vanden Meerschaut et al.,
2014b) and so is their language development (D’haeseleer
et al., 2014).
Most likely, it is the rather inﬂationary use of AOA sub-
stances that has led some scientists to comment on the im-
minent scenario of using AOA, particularly Ca2+-ionophores,
as a routine procedure (Santella and Dale, 2015; van Blerkom
et al., 2015). These authors consider ionophores as still “ex-
perimental”, which they actually are, and the authors of this
comment fully support that notion. A more open-minded com-
mentary dealing with ionophore has stated that “it is deﬁn-
ing modiﬁcations in treatment strategies that concurrently
advances our knowledge of human fertilization and opens new
avenues for research into the subcellular complexity of the
earliest stages of development” (Albertini, 2015). This re-
ﬂects the history of IVF, where we have to acknowledge that
certain procedures were introduced without full understand-
ing of the underlying mechanism. Moving forward does imply
following a line that transfers a procedure from research to
experimental to clinical. The history of AOA is probably one
of the best examples and is currently in the transition process
from experimental to clinical – provided that it is applied with
a proper indication. To conclude, there is deﬁnitely a need
for more prospective studies with a larger number of pa-
tients to conﬁrm the observations so far and to further address
the safety of AOA.
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